2026 ILD Symposium
An advanced CE-accredited afternoon symposium exploring the evolving treatment paradigm in interstitial lung disease, including clinical development, imaging, CTD-ILD, sarcoidosis, and challenging ILD cases.
Educational Outcome
This CE activity provides healthcare professionals with expert-led education on the evolving diagnosis and management of interstitial lung disease (ILD), including advances in screening, treatment algorithms, imaging, and emerging therapies. Participants will gain practical insights into IPF, PPF, CTD-ILD, sarcoidosis, and complex ILD management strategies to support earlier recognition, evidence-based treatment decisions, and improved patient outcomes.
Course Objectives
After completing this activity, the participant should be better able to:
- Describe the pathophysiology of interstitial lung disease and apply current screening protocols and treatment algorithms to optimize diagnosis and patient management
- Evaluate current and emerging approaches to ILD screening, imaging, and treatment algorithms, as well as novel diagnostic technologies
- Apply advances in ILD imaging to improve early detection, disease monitoring, and risk stratification across ILD subtypes
- Recognize the distinguishing clinical features and management considerations for special populations, such as CTD-ILD and sarcoidosis
Target Audience
This activity is designed for pulmonologists, rheumatologists, radiologists, cardiologists, internists, fellows, advanced practice providers, nurses, pharmacists, and other healthcare professionals engaged in the multidisciplinary care of patients with interstitial lung disease.
For more information and to register, please visit https://www.ildsymposium.com/#home
